|
| |
GE Healthcare to Host 'Current Trends in
Microcalorimetry and Biacore Symposium'
Addressing functional characterization of biomolecular stability and
interactions
Uppsala, Sweden, 18th June 2009 – GE Healthcare, a unit of General
Electric Company (NYSE: GE), will host ‘Current Trends in Microcalorimetry and
Biacore Symposium 2009’, on October 18-21 at the Renaissance Harborplace Hotel,
Baltimore, MD, USA. The symposium offers delegates an exciting opportunity for
exchange and discussion on all the latest developments in label-free molecular
interaction analysis.
This symposium brings together two previously held events, ‘Current Trends in
Microcalorimetry’ (previously hosted by MicroCal, now part of GE Healthcare) and
‘Biacore Symposium’ (also known as DiPIA). The meeting is expected to attract
around 300 delegates involved in functional characterization of biomolecular
stability and interactions.
The event will feature a series of in depth oral presentations and poster
sessions from leading scientists in industry and academia, as part of scientific
sessions organized around five main topic areas:
- Systems Biology & Proteomics
o Speaker - Richard Kriwacki, St. Jude Children's Research Hospital: “Functional
mechanisms of disordered proteins; Insights from ITC, SPR and other methods”
- Nucleic Acids & Glycoproteins
- Small-Molecule Drug Discovery & Development
o Keynote speaker - Ernesto Freire, Johns Hopkins University: "Thermodynamic
rules for the optimization of drug candidates."
- Biotherapeutics Discovery & Development
o Speaker - Stephen Demarest, Biogen Idec: "Mechanism of action studies of
anti-insulin-like growth factor antibodies using MicroCal™ ITC200 and Biacore™
to develop a Best-in-Class biotherapeutic."
o Speaker - Muralidhara Bilikallahalli, Pfizer: “Unique applications of
Isothermal Titration Calorimetry in formulation and development of biologics”
- Novel Methods for Biophysical Characterization of Biomolecular Interactions
Participants will also have the opportunity to take part in detailed tutorials
addressing the use of MicroCal and Biacore instrument platforms, as well as
educational workshops such as "Working with Small Molecules and Fragments" and
"Techniques for Protein Expression and Purification".
For a full schedule and registration details please visit:
www.biacore.com/symposium2009
The event is kindly sponsored by Science and Pharma.
-ENDS-
ABOUT GE HEALTHCARE:
GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical imaging
and information technologies, medical diagnostics, patient monitoring systems,
drug discovery, biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our customers to deliver
better care to more people around the world at a lower cost. In addition, we
partner with healthcare leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on
our journey as we continuously develop innovations focused on reducing costs,
increasing access and improving quality and efficiency around the world.
Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of
General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than
46,000 people committed to serving healthcare professionals and their patients
in more than 100 countries. For more information about GE Healthcare, visit our
website at www.gehealthcare.com .
Contact
College Hill
Lynne Trowbridge, Katie Odgaard, Rebecca Walker
+44 (0)20 7457 2020
ge-proteins@collegehill.com
| |
|
